Refractory pulmonary sarcoidosis: incidence after treatment with methylprednisolone and/or methotrexate in patients with newly diagnosed disease

Abstract

The high rate of conventional therapy failure using first- and second-line medications in patients with newly diagnosed sarcoidosis determines the relevance of further study of the causes, development of risk criteria and new approaches to the treatment of refractory pulmonary sarcoidosis.